Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

Lee, Young-Ho; Liu, Xiyong; Qiu, Fuming; O'Connor, Timothy R; Yen, Yun; Ann, David K · PLoS One · 2015

Where this comes from

Record sourced from PubMed, PMID 25875848.
Also identified by DOI 10.1371/journal.pone.0124853 and PMC identifier 4395453.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0121207.].

Read the full text

View on PubMed · Publisher (DOI)